Metraipolis › archive › dc_bf88dc2c4e3a

Clinical application of HMGB1-TLR4 signaling pathway-mediated neuroinflammatory markers in infantile epileptic spasms syndrome — Europe PMC PMID:42148092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42148092
DOI
10.3389/fimmu.2026.1801505
License (as archived)
solo-consultazione
Archived
2026-10-17T11:13:22.672Z
SHA-256 of the archived text
26ce2d555718836fc181d6d1c3832d6a2224d32be9fbb5cd30c9fffc7f4ca9e4
Stable URL of this page
https://metraipolis.com/documento/dc_bf88dc2c4e3a

How to cite

Clinical application of HMGB1-TLR4 signaling pathway-mediated neuroinflammatory markers in infantile epileptic spasms syndrome — Europe PMC PMID:42148092 — Europe PMC (en), https://europepmc.org/article/MED/42148092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf88dc2c4e3a (Metraipolis archive dc_bf88dc2c4e3a, sha256 26ce2d555718836fc181d6d1c3832d6a2224d32be9fbb5cd30c9fffc7f4ca9e4)
BibTeX
@misc{dcbf88dc2c4e3a,
  title = {Clinical application of HMGB1-TLR4 signaling pathway-mediated neuroinflammatory markers in infantile epileptic spasms syndrome — Europe PMC PMID:42148092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf88dc2c4e3a; sha256 26ce2d555718836fc181d6d1c3832d6a2224d32be9fbb5cd30c9fffc7f4ca9e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148092. Agents can read the archived copy with the MCP tool read_document.